在儿童严重喘中使用生物疗法
Cristiana Indolfi1, Angela Klain1, Michele Miraglia Del Giudice1
1Department of Woman, Child and General and Specialized Surgery, University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Expert review of respiratory medicine
|August 5, 2025
概括
生物疗法为重症儿科喘提供有针对性的治疗,改善生活质量. 本综述涵盖了已批准的生物药物,新兴药物和未来的研究方向,以更好地管理喘.
科学领域:
- 儿科肺病学 儿科肺病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童严重喘是一种复杂的慢性疾病,影响日常生活.
- 传统的治疗方法在管理异质儿科喘表型方面存在局限性.
- 生物疗法已经成为针对性干预的转型方法.
研究的目的:
- 审查目前关于儿童严重喘批准的生物疗法的证据.
- 讨论作用机制,临床试验数据和现实世界的证据.
- 探索新兴的生物药物和儿童喘缓解的概念.
主要方法:
- 在PubMed,Embase和会议记录中进行全面的文献搜索,截至2025年5月.
- 对已批准的生物制剂进行关键临床试验和现实数据的分析.
- 检查针对上游炎症通路的新兴药物的检查.
主要成果:
- 奥马利祖马布,梅波利祖马布,本拉利祖马布和杜皮卢马布是经过批准的生物药物,其有效性已被证明.
- 新兴的药物,如tzepelumab和抗IL-33疗法,显示出有希望的结果.
- 目前正在研究关于长期结果和喘缓解的可能性的数据.
结论:
- 生物药物代表了个性化儿科喘管理的重大进步.
- 优化患者选择,获取和理解长期影响仍然是关键挑战.
- 未来的研究应该专注于早期干预,成本效益和疾病修饰.
相关概念视频
Asthma: Pathogenesis and Management
593
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
593
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
461
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
461
Antiasthma Drugs: Leukotriene Modifiers
475
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
475
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
394
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
394
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K


